Video & Transcript Research : 'THCa'

Page 1 of 2
NH

New Hampshire 2026 Regular Session

Senate Judiciary (02/10/2026)

Judiciary

Transcript Highlights:
  • THCA is not an isomer of THC.
  • THCA because if THCA any isomer or any THCA because if THCA is<01:25:31.520> smoked<01:25:31.840
  • says the isomers and THCA. says the isomers and THCA.
  • We always treat THCA as a form of THC. We always treat THCA as a form of THC.
  • and it will include the content of THCA. and it will include the content of THCA.
Keywords: 1191, senate, all
NH

New Hampshire 2026 Regular Session

Senate Judiciary (01/22/2026)

Judiciary

Transcript Highlights:
  • THCA flour. It's less than.3% THCA flour.
  • And the dispensaries are predominantly selling THCA products. This is a THCA vape product.
  • c> THCA products.
  • This is a THCA THCA products. This is a THCA vape<01:26:42.719> product.
  • we do understand that heating up THCA we do understand that heating up THCA causes<01:27:24.080>
Keywords: 1191, senate, all
NH

New Hampshire 2026 Regular Session

House Criminal Justice and Public Safety (03/18/2026)

Criminal Justice and Public Safety

Transcript Highlights:
  • and THCA labeled as THCA flour and THCA concentrates<02:22:14.960> under<02:22:15.200> the
  • But they have dispensaries everywhere selling THCA flower, THCA vapes, THCA concentrates, THC edibles
  • , THCA vapes, THCA concentrates, flour, THCA vapes, THCA concentrates, THC<02:29:31.760> edibles,<
  • isolate 54% THCA. isolate 54% THCA.
  • THC diamonds 99% THCA. THC diamonds 99% THCA.
Keywords: 1189, house, all
NH

New Hampshire 2026 Regular Session

House Criminal Justice and Public Safety (04/30/2026)

Criminal Justice and Public Safety

Transcript Highlights:
  • This is a THCA product that is inhalable.
  • This is a THCA product that is inhalable.
  • This is a THCA product that is inhalable.
  • THC delta 8 or THCA. The other thing THC delta 8 or THCA.
  • We just saw have THCA. There's THCO.
Keywords: 1189, house, all
MO

Missouri 2026 Regular Session

Crime and Public Safety Jan 13th, 2026

Crime and Public Safety

Transcript Highlights:
  • because at the end of the day, THCA flower is marijuana.
  • I understand THCA and THC and the differences.
  • Well, we're not telling THC, we're telling THCA.
  • So is THCA, sir. And so is marijuana in the state. Well, according to the DEA, THCA is not.
  • And it's the same in the THCA.
Keywords: 959, house, all
NH

New Hampshire 2026 Regular Session

House Environment and Agriculture (03/31/2026)

Environment and Agriculture

Transcript Highlights:
  • we hadn't considered things like THCA we hadn't considered things like THCA prior. prior. prior.
  • And then it obviously, concentrate THCA.
  • or THCA? or THCA?
  • pull THCA almost weekly pull THCA products<03:56:14.840> off<03:56:15.000> the<03:56:15.120
  • It says right on these labels that they're THCA.
Keywords: 1189, house, all
TX

Texas 89th 1st C.S.

State Affairs Jul 22nd, 2025

State Affairs

Transcript Highlights:
  • They grow the flower, and what they add is a component, THCA.
  • Total THC cannot be under 0.3% if you consider the THCA component.
  • So THCA is a different compound than THC. It's a precursor. It's flower. THCA refers to flower.
  • Well, THCA and THC are very different things. They actually are.
  • Well, THCA and THC are very different things. They actually are.
Bills: SB 5, SB 11, SB 12
Summary: The Senate Committee on State Affairs took up Senate Bill 5, which Senator Perry described as a ban on intoxicating THC consumer products while preserving legal CBD, CBG, hemp seed, hemp seed protein powder, and hemp seed oil products. Perry argued that most retail THC products are already illegal under federal law, that the industry has used loopholes and misleading labeling to sell high-potency products, and that regulation would be ineffective because chemists can quickly alter formulations. He also said the bill would steer people with medical needs toward the Texas Compassionate Use Program (T-Cup), which he and other supporters described as the proper physician-guided alternative. Committee members and witnesses repeatedly discussed the distinction between legal hemp-derived products and intoxicating THC products, and Perry said the bill would not touch non-consumable hemp uses such as fiber and clothing. Invited testimony came from law enforcement and medical witnesses who supported the bill. Texas Police Chiefs Association representative Steve Dye, Kaufman County District Attorney Early Wiley, and Chambers County Sheriff Brian Hawthorne all said regulation would be too costly, too complex, and ultimately unenforceable, while a ban would be clearer and easier to enforce. They cited overloaded DPS labs, the need for expensive private testing, limited police and prosecutor resources, and the difficulty of keeping up with constantly changing cannabinoids and out-of-state products. Hawthorne and Wiley described raids and investigations involving warehouses, retail stores, cash seizures, and products they said were marketed to young people and often mislabeled or imported from other states. They also said the bill would help law enforcement by creating a clearer legal line and protecting legitimate CBD/CBG businesses. Dr. Lindy McGee, speaking for the Texas Medical Association and Texas Pediatric Society, testified that retail THC products pose serious risks to children and adolescents, including addiction, impaired brain development, psychosis, suicide attempts, self-harm, accidental toddler ingestions, and possible long-term cognitive effects. She said there is no effective medication treatment for THC addiction comparable to nicotine cessation tools, and she supported restrictions such as child-resistant packaging, no marketing to minors, and age limits, while opposing criminal penalties for possession by minors. Senators asked follow-up questions about brain development, memory, dementia risk, pregnancy, and cardiovascular effects. No vote was taken during the portion provided, and the committee continued with invited testimony and questions.
HI

Hawaii 2025 Regular Session

JHA Public Hearing - Tue Feb 25, 2025 @ 2:00 PM HST

Judiciary & Hawaiian Affairs

Transcript Highlights:
  • So it doesn't cover HHC, THCA, THCP, or THCO.
  • So it doesn't cover HHC, THCA, THCP, or THCO.
  • a concern, but absolutely that, you know, it could be adulterated with anything, whether it's just THCA
  • a concern, but absolutely that, you know, it could be adulterated with anything, whether it's just THCA
  • a concern, but absolutely that, you know, it could be adulterated with anything, whether it's just THCA
Keywords: 910, house, all
Summary: The committee first heard House Bill 302, which would repeal the requirement that a provider-patient relationship for medical cannabis certification be established in person first. The Department of Health said it supported the House Draft 2 version as a way to expand patient access, and several testifiers from the medical cannabis community and dispensary industry supported the bill, especially for patients on outer islands or those unable to travel. One witness asked that earlier language removed in committee be restored to further improve access. Representative Shimizu asked whether follow-up in-person visits would still occur, and DOH responded that this varies by provider, with some continuing in-person care and others moving to telehealth for chronic conditions. The committee then took up House Bill 712, relating to the federal 340B drug pricing program and contract pharmacies. The Office of Consumer Protection and the Attorney General’s office both said they supported the bill’s purpose but wanted it clarified and possibly moved into a standalone chapter rather than chapter 481B. Supporters, including Hawaii Pacific Health and the Queen’s Health Systems, said the bill is needed to protect safety-net funding and access to discounted drugs, citing large financial benefits from 340B and losses caused by manufacturer restrictions on contract pharmacies. PhRMA opposed the bill, arguing the issue is not access to discounts but accountability and transparency in how contract pharmacies distribute benefits, and said it was willing to discuss amendments. Members asked follow-up questions about whether there was data showing misuse; PhRMA said it did not have numbers, while hospital witnesses said the program is federally audited and used appropriately in Hawaii. Finally, the committee heard House Bill 1482, HD1, which would tighten hemp and controlled-substance definitions to exclude Schedule I cannabinoids from manufactured hemp products and clarify the treatment of artificially derived cannabis. The Department of Health supported the measure, saying it adds clarity to existing prohibitions. Kūre Hawaii and other supporters said it would close loopholes involving Delta-8 and similar products. An individual testifier urged stronger language to also cover compounds such as HHC, THCA, THCP, and THCO. In response to questions about enforcement against mislabeled hemp products, DOH explained that THC percentages are relative to product weight, that some products can remain under the hemp threshold while still containing significant THC, and that hemp flower is already prohibited from direct retail sale, though enforcement can be complicated and involves both administrative and criminal authorities.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Cannabis Policy Jun 21st, 2026 at 10:30 am

Joint Committee on Cannabis Policy

Transcript Highlights:
  • you know, in the process, I believe, the commercial products are required to have the THC amount, THCA
  • you can buy at my friend Pete's dispensary, that is psychoactive, will get you high, but it's called THCA
  • fact, even worse, they contain some synthetics like HHC, THCP, which are much, much more potent than THCA
  • I had heard THCA referenced earlier in testimony, and while the Farm Bill does not include THC that allows
  • that federal loophole, Massachusetts has codified the definition of hemp that does include THCA, meaning
Keywords: 995, all
Summary: The Joint Committee on Cannabis Policy held a hearing on a broad set of cannabis and hemp bills, with the chairs opening by emphasizing unfinished work on equity, public health, safety, and market stability. The committee heard testimony on House Bill 146, which would create more efficient cannabis testing standards by increasing batch sizes, reducing or eliminating some environmental testing, standardizing lab reporting, and requiring annual scientific review and public data reporting. Industry witnesses, including a representative of the Massachusetts Cannabis Coalition, cultivators, and a testing lab owner, said current testing rules are overly burdensome, costly, and inconsistent, and argued the bill would lower compliance costs while preserving consumer safety. A testing lab witness also said some operators switch labs to obtain higher THC results or pass contaminated batches, and urged greater transparency and better sampling protocols. A major portion of the hearing focused on intoxicating hemp and related bills that would bring hemp-derived intoxicating products under a stronger regulatory framework. Legislators and industry witnesses described products sold in gas stations, smoke shops, and convenience stores as often untested, not age-gated, and sometimes mislabeled or far above the federal hemp THC threshold. Testimony from attorneys and cannabis business leaders said states can regulate these products more strictly under the Farm Bill’s non-preemption language, and pointed to New Jersey and other states as possible models. Some witnesses and committee members stressed that any new rules should avoid harming non-intoxicating CBD businesses or lawful hemp farmers, while others argued that the products are effectively cannabis and should be regulated like cannabis for licensing, testing, age limits, and taxation. The committee also heard extensive public-health testimony in support of bills S. 95, S. 96, S. 97 and their House counterparts H. 191, H. 192, and H. 193. Parents, advocates, and public health professionals urged stronger warning labels, THC potency caps, and improved data collection on cannabis-related harms, citing cannabis-induced psychosis, addiction, anxiety, and youth exposure to high-potency products. Several witnesses said Massachusetts has not done enough to track health outcomes or warn consumers, and referenced other jurisdictions such as Connecticut, Vermont, Colorado, Canada, and Quebec as examples of stronger limits or warnings. No votes or formal actions were taken during the hearing; the committee primarily received testimony and questions.
TX
Transcript Highlights:
  • They grow the flower, and what they add is a component, THCA.
  • It also contains traces of CBN, THCA, CBDA, and THCV.
  • THC total cannot be under 0.3% if you consider the THCA component.
  • There's THCA flour.
  • See, if I take THCA, I get lazy, I get kind of lethargic. But it also makes me hungry.
Bills: SB5, SB11, SB12, SB 5, SB 11, SB 12
TX

Texas 89th 1st C.S.

Public Health Aug 13th, 2025

Public Health

Transcript Highlights:
  • You'll be okay, but if I don't, then I could get... they don't know if it's going to be either THCA or
  • So we are having some struggle with that and THCA and what that means when it's heated.
  • Some states have considered enabling THC gummies and beverages to be sold, but not THCA flower.
  • Some states have considered enabling THC gummies and beverages to be sold, but not THCA flour.
  • So THC occurs in the plant first as THCA, which is the acid form.
Summary: The House Committee on Public Health heard House Bill 5, a proposal to ban THC products outside the Texas Compassionate Use Program while allowing non-intoxicating CBD and CBG products under tighter regulation. Chair Van Deaver gave a lengthy background on the 2018 federal Farm Bill and Texas’s 2019 hemp law, arguing that the lack of guardrails allowed a large, unregulated THC market to develop. HB 5 would impose licensing fees, product registration, testing and inspection requirements, and restrictions intended to keep products away from children. Invited witnesses from law enforcement strongly supported the bill. Steve Dye of the Texas Police Chiefs Association and Brian Hawthorne of the Sheriffs’ Association of Texas argued that THC consumables are widely mislabeled, often far more potent than advertised, and linked to youth access, impaired driving, and organized crime. Both said regulation would be ineffective and would amount to legalization, while a ban would be easier for officers to enforce. They also emphasized support for the Texas Compassionate Use Program and said medical THC should remain available. Dr. Peter Stout of the Texas Association of Crime Lab Directors and Alice Amelot of Texas DPS testified as resource witnesses about forensic testing. They said current lab resources are already stretched thin, that quantitative testing for THC and related cannabinoids is expensive and time-consuming, and that a ban would simplify enforcement because labs could focus on presence/absence testing rather than concentration. Amelot said DPS labs are neutral on the bill but explained that mislabeled products and inaccurate certificates of analysis are common. Committee members asked about traffic safety, impairment, youth use, and the costs of enforcement and lab testing; witnesses repeatedly said the bill would reduce complexity for law enforcement but that any approach would still require more resources for labs.
NH

New Hampshire 2026 Regular Session

Senate Judiciary (02/17/2026)

Judiciary

Transcript Highlights:
  • Uh, we added THCA into several areas that testified that we should emphasize the need to prohibit the
  • THCA in there.
  • areas that um um THCA in to several areas that um um testified<00:15:38.000> that<00:15:38.320
  • c><00:15:40.639> to<00:15:41.120> prohibit<00:15:41.440> the<00:15:41.680> THCA
  • the need to prohibit the THCA in there. the need to prohibit the THCA in there.
Keywords: 1191, senate, all
TX

Texas 89th Regular

State Affairs Apr 7th, 2025 at 03:30 pm

State Affairs

Transcript Highlights:
  • THCA flour and hemp products will still ship legally from out-of-state vendors thanks to federal law.
  • Will you add Cachet, THCA to... I'd like to speak on behalf...
  • It's a retail establishment specializing in THCA, CBD, and hemp products.
  • So, to do that, they get what I mentioned earlier, THCA and Delta 9.
  • And let's be clear, this isn't just about CBD, CBD- CBG or THC, it's about CBDA, CBGA, CBCA, THCA, CRD
Bills: HB 28, SB 3
Summary: The meeting featured significant discussions regarding HB28, where the chair outlined the plans to bring forward a substitute for the bill. The chair emphasized the importance of maintaining order and decorum during the proceedings. Members engaged in deliberations, and a number of public witnesses were invited to testify, thereby enriching the discussion around the bill. This interaction provided valuable insights into public sentiment regarding the issues at hand.
TX

Texas 89th Regular

State Affairs Apr 7th, 2025

State Affairs

Transcript Highlights:
  • THCA flower and hemp products will still ship legally from out-of-state vendors thanks to federal law
  • Will you add Cache, THCA, to... I'd like to speak on behalf.
  • It's a retail establishment specializing in THCA, CBD, and hemp products.
  • That changed when I found type 2 CBD and THCA hybridized hemp flower, used in conjunction with dry herb
  • federally legal THCA into over.
Bills: SB 3, HB28, SB3
AL

Alabama 2025 Regular Session

Alabama House Health Committee Apr 2nd, 2025

Health

Transcript Highlights:
  • But not only do we have Delta 8, we have THCP 20 milligrams, Delta 9, 12 milligrams, the THCA 3...
  • THCA 3 milligrams. I don't know if I should have gloves holding this.
Bills: HB441, HB445, HB477, HB441, HB445
NH

New Hampshire 2026 Regular Session

House Environment and Agriculture (04/14/2026)

Environment and Agriculture

Transcript Highlights:
  • , for example, all the products that we are currently encountering with the THCA to say they're THCA,
  • c><02:44:17.960> are<02:44:18.080> seeing,<02:44:18.520> the<02:44:18.640> THCA
  • , terms of what we are seeing, the THCA, terms of what we are seeing, the THCA, for<02:44:19.480>
  • are currently encountering with the THCA are currently encountering with the THCA to<02:44:22.880
  • > they're<02:44:24.360> THCO, to say they're THCA, say they're THCO, to say they're THCA
Keywords: 1189, house, all
NH
Transcript Highlights:
  • targeting the particular thing they might need, which surprisingly often is, say, non-intoxicating THCA
  • non- surprisingly often is say non- surprisingly often is say non- intoxicating<00:46:04.480> thca
  • <00:46:05.280> is<00:46:05.400> an intoxicating thca is an intoxicating thca is an
Keywords: 928, house, all
Summary: The work session focused on HB 54, which would allow New Hampshire’s alternative treatment centers to operate for profit. Chair David Nagel opened by identifying the main concerns: whether members agreed with the bill conceptually, whether the proposal could be shaped to avoid a gubernatorial veto, and whether it could lead to “big cannabis” taking over. He also emphasized that the bill would not change the existing oversight structure, which remained under RSA 126-X. Representative Wendy Thomas said the governor’s objections in past sessions appeared to center on the state’s preference for a state-run model and broader policy concerns, but no one present knew the current governor’s position. Several speakers argued the bill was primarily about financing and access, not expanding the number of dispensaries. Matt Simon of Granite Leaf Cannabis said the current nonprofit structure makes it difficult to raise capital, pay down debt, and open additional access points, and that the bill would be a corporate restructuring rather than a change in day-to-day regulation. Brandon Pollock of TASCAL Wellness said medical cannabis programs in most other states are for-profit, and that New Hampshire’s nonprofit requirement has left ATCs burdened with high-interest debt and higher prices that push patients to Maine, Vermont, or the street market. He said converting to for-profit status could allow conventional financing, lower prices, and help keep patients in the regulated program. Members also discussed whether for-profit ownership would invite outside corporate control. Witnesses said the bill would not open the market to new operators, would not change advertising rules, and would include restrictions on ownership transfers for a period of time; “foreign corporation” was explained as an out-of-state entity. One speaker noted that the bill is similar to earlier versions that passed both chambers with strong support but never became law. No vote was taken during the work session; the discussion was informational and aimed at addressing concerns before the bill moved forward.
TX
Transcript Highlights:
  • They move away from the narrow Delta-9-THC-only approach and toward total THC, including THCA and all
  • It's naturally occurring in the cannabis plant, tetrahydrocannabinolic acid, THCA.
  • know if a product, if your agency goes into one of these shops, and you now have prohibitions against THCA
  • And almost every smoke shop I've gone to in Texas has sold 99% THCA concentrate. Say that.
  • every single smoke shop I've gone to in Texas—I've gone to tons—almost all of them are selling 99% THCA
Keywords: 1185, senate, all